Resources

MyEvaluations

Harlem Hospital Center’s Internal Medicine Residency Program utilizes an online evaluation management system called My Evaluations. The system can be accessed securely through the internet at www.MyEvalutions.com. Residents can use this system to track evaluations, procedures, conference and clinic attendance, etc.

MyEvalutions.com Orientation (PDF, 13MB)

Internal Medicine Clinical Journals

  • New England Journal of Medicine
  • Annals of Internal Medicine
  • The Lancet
  • Journal of Internal Medicine
  • Journal of the American Medical Association
  • Archives of Internal Medicine
  • The American Journal of Medicine
  • References for statistics at Journal Club

    1. Bland JM, Altman DG  Correlation, regression and repeated data. BMJ 1994; 308: 896.
    2. Bland JM, Altman DG. Regression towards the mean. BMJ 1994; 308: 1499.
    3. Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. BMJ 1994; 308: 1552.
    4. Altman DG, Bland JM. Diagnostic tests 2: predictive values. BMJ 1994; 309: 102.
    5. Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ 1994; 309: 188.
    6. Bland JM, Altman DG. One- and two-sided tests of significance. BMJ 1994; 309: 248.
    7. Bland JM, Altman DG. Some examples of regression towards the mean. BMJ 1994; 309: 780.
    8. Altman DG, Bland JM. Quartiles, quintliles, centiles, and other quantiles. BMJ 1994; 309: 996.
    9. Bland JM, Altman DG. Matching. BMJ 1994; 309: 1128.
    10. Altman DG, Bland JM. The normal distribution. BMJ 1995; 310: 298.
    11. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 311: 485.
    12. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
    13. Altman DG, Bland JM. Presentation of numerical data. BMJ 1996; 312: 572.
    14. Bland JM, Altman DG. Logarithms. BMJ 1996; 312: 700.
    15. Bland JM, Altman DG. Transforming data. BMJ 1996; 312: 770.
    16. Bland JM, Altman DG. Transformations, means and confidence intervals. BMJ 1996; 312: 1079.
    17. Bland JM, Altman DG. The use of transformations when comparing two means. BMJ 1996; 312: 1153.
    18. Altman DG, Bland JM. Comparing several groups using analysis of variance. BMJ 1996; 312: 1472–1473.
    19. Bland JM, Altman DG. Measurement error. BMJ 1996; 313: 744
    20. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ 1996; 313: 41–42.
    21. Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996; 313: 106.
    22. Altman DG, Matthews JNS. Interaction 1: Heterogeneity of effects. BMJ 1996; 313: 486.
    23. Matthews JNS, Altman DG. Interaction 2: compare effect sizes not P values. BMJ 1996; 313: 808.
    24. Matthews JNS, Altman DG. Interaction 3: How to examine heterogeneity. BMJ 1996; 313: 862.
    25. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996; 313: 1200.
    26. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997; 314: 572.
    27. Altman DG, Bland JM. Units of analysis. BMJ 1997; 314: 1874.
    28. Bland JM, Kerry SM. Trials randomised in clusters. BMJ 1997; 315: 600.
    29. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. BMJ 1998; 316: 54.
    30. Bland JM, Kerry SM. Weighted comparison of means. BMJ 1998; 316: 129.
    31. Kerry SM, Bland JM. Sample size in cluster randomisation. BMJ 1998; 316: 549.
    32. Altman DG, Bland JM. Generalisation and extrapolation. BMJ 1998; 317: 409–410.
    33. Altman DG, Bland JM. Time to event (survival) data. BMJ 1998; 317: 468–469.
    34. Bland JM, Altman DG. Bayesians and frequentists. BMJ 1998; 317: 1151.
    35. Bland JM, Altman DG. Survival probabilities (the Kaplan-Meier method). BMJ 1998; 317: 1572.
    36. Altman DG, Bland JM. Treatment allocation in controlled trials: why randomise? BMJ 1999; 318: 1209.
    37. Altman DG, Bland JM. Variables and parameters. BMJ 1999; 318: 1667.
    38. Altman DG, Bland JM. How to randomise. BMJ 1999; 319: 703–704.
    39. Bland JM, Altman DG. The odds ratio. BMJ 2000; 320: 1468.
    40. Day SJ, Altman DG. Blinding in clinical trials and other studies. BMJ 2000; 321: 504.
    41. Altman DG, Schulz KF. Concealing treatment allocation in randomised trials. BMJ 2001; 323: 446–447.
    42. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323: 1123–1124.
    43. Bland JM, Altman DG. Validating scales and indexes. BMJ 2002; 324: 606–607.
    44. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219.
    45. Bland JM, Altman DG. The logrank test. BMJ 2004; 328: 1073.
    46. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329: 168–169.
    47. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ 2005; 330: 843.
    48. Altman DG, Bland JM. Standard deviations and standard errors. BMJ 2005; 331: 903.
    49. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ 2006; 332: 1080.
    50. Altman DG, Bland JM. Missing data. BMJ 2007; 334: 424.